Tag: Stents
Cre8 EVO Stents Noninferior for PCI in Diabetes Patients With CAD
Cre8 EVO stents noninferior to Resolute Onyx stents for target-lesion failure composite outcome at one year
QFR-Guided Percutaneous Coronary Intervention Improves Outcomes
One-year clinical outcomes improved with quantitative flow ratio for lesion selection versus standard angiography guidance
FFR-Guided PCI Not Noninferior to CABG in Three-Vessel CAD
Findings not consistent with prespecified noninferiority of fractional flow reserve-guided percutaneous coronary intervention
Impact of Age Examined for Ticagrelor Monotherapy After PCI
Ticagrelor monotherapy reduces bleeding without increasing ischemic events among patients undergoing PCI
Ticagrelor, Prasugrel Compared in ACS Treated With PCI
Prespecified subgroup analysis of data from a randomized clinical trial suggest that a prasugrel-based strategy is preferable
Deaths Not Up With Paclitaxel-Coated Devices in PAD
Interim analysis shows no increased rate of all-cause mortality with paclitaxel-coated versus uncoated devices
Polymer-Based Stents Noninferior for Patients With High Bleeding Risk
Polymer-based zotarolimus-eluting stents noninferior for patients at high bleeding risk undergoing PCI
Many Patients Overestimate the Benefits of PCI
Study of the informed consent process reveals 60 percent of patients mistakenly believe PCI is curative
No Increased Mortality Seen With Paclitaxel Drug-Eluting Devices
In safety analysis, long-term mortality did not increase with use of paclitaxel-based devices
PCI, CABG for Left Main CAD Have Similar Five-Year Outcomes
Findings reported for composite outcomes for 1,905 patients with left main coronary artery disease
